Mucinous Ovarian Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Endometrial Clear Cell Carcinoma;  Endometrial Papillary Serous Carcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Tumor;  Recurrent Endometrial Carcinoma;  Recurrent Fallopian Tube Cancer;  Recurrent Ovarian Epithelial Cancer;  Recurrent Primary Peritoneal Cavity Cancer;  Stage IIIA Fallopian Tube Cancer;  Stage IIIA Ovarian Epithe...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Adult Solid Neoplasm;  Endometrial Clear Cell Adenocarcinoma;  Endometrial Serous Adenocarcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Neoplasm;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Recurrent Primary Peritoneal Carcinoma;  Recurrent Uterine Corpus Carcinoma;  Stage IIIA Fallopian Tube Cancer;  StageÂ...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Adult Solid Neoplasm;  Endometrial Clear Cell Adenocarcinoma;  Endometrial Serous Adenocarcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Neoplasm;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Recurrent Primary Peritoneal Carcinoma;  Recurrent Uterine Corpus Carcinoma;  Stage IIIA Fallopian Tube Cancer;  StageÂ...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Adult Solid Neoplasm;  Endometrial Clear Cell Adenocarcinoma;  Endometrial Serous Adenocarcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Neoplasm;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Recurrent Primary Peritoneal Carcinoma;  Recurrent Uterine Corpus Carcinoma;  Stage IIIA Fallopian Tube Cancer;  StageÂ...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Endometrial Clear Cell Carcinoma;  Endometrial Papillary Serous Carcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Tumor;  Recurrent Endometrial Carcinoma;  Recurrent Fallopian Tube Cancer;  Recurrent Ovarian Epithelial Cancer;  Recurrent Primary Peritoneal Cavity Cancer;  Stage IIIA Fallopian Tube Cancer;  Stage IIIA Ovarian Epithe...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions:  Adult Giant Cell Glioblastoma;  Adult Glioblastoma;  Adult Gliosarcoma;  Endometrial Clear Cell Carcinoma;  Endometrial Papillary Serous Carcinoma;  Ovarian Clear Cell Cystadenocarcinoma;  Ovarian Endometrioid Adenocarcinoma;  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Serous Cystadenocarcinoma;  Recurrent Adult Brain Tumor;  Recurrent Endometrial Carcinoma;  Recurrent Fallopian Tube Cancer;  Recurrent Ovarian Epithelial Cancer;  Recurrent Primary Peritoneal Cavity Cancer;  Stage IIIA Fallopian Tube Cancer;  Stage IIIA Ovarian Epithe...
Source: ClinicalTrials.gov - May 16, 2014 Category: Research Source Type: clinical trials
